Table 4.
SNP | Genotype | N | Initial sample | Replication sample | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lifetime tic severity Mean (SD) a |
Cumulative pre- and perinatal adversity score Mean (SD) b |
β | Standard error | T |
P
c, d (Genotype) |
N | β | Standard error | T |
P
c, d (Genotype) |
|||
rs6539267 | TT | 250 | 15.3 (8.20) | 3.30 (3.32) | – | 352 | |||||||
CT | 224 | 15.7 (7.80) | 3.77 (3.76) | 0.039 | 0.21 | − 1.87 | 0.06 | 344 | 0.74 | 0.61 | 1.20 | 0.23 | |
CC | 40 | 15.2 (9.62) | 3.9 (3.75) | 1.12 | 0.42 | 2.62 | 0.009 | 82 | − 0.03 | 1.00 | − 0.03 | 0.98 |
SNP single-nucleotide polymorphism
aLifetime worst-ever tic severity was assessed based on a modified version of the Yale Global Tic Severity Scale (Dietrich et al. 2015)
bCumulative pre- and perinatal adversity score (previously described in Abdulkadir et al. 2016) was constructed from addition of 38 possible adverse events as measured by the self-report or parent-on-child report version of the Modified Schedule for Risk and Protective Factors Early in Development questionnaire (Walkup and Leckman 1988)
cAnalyses were corrected for age, sex, and socioeconomic status
dMajor allele homozygous genotype was used as the reference genotype